Total Payments
$16,083
2024 Payments
$3,140
Companies
79
Transactions
838
Medicare Patients
4,975
Medicare Billing
$504,670
Payment Breakdown by Category
Food & Beverage$14,942 (92.9%)
Education$1,140 (7.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $14,942 | 805 | 92.9% |
| Education | $1,140 | 33 | 7.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,760 | 105 | $0 (2024) |
| Merck Sharp & Dohme LLC | $1,389 | 73 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $1,275 | 78 | $0 (2024) |
| PFIZER INC. | $1,088 | 62 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $682.22 | 21 | $0 (2024) |
| Daiichi Sankyo Inc. | $630.63 | 25 | $0 (2024) |
| Amgen Inc. | $574.40 | 34 | $0 (2024) |
| Astellas Pharma US Inc | $542.46 | 21 | $0 (2024) |
| Janssen Biotech, Inc. | $520.38 | 33 | $0 (2024) |
| Exelixis Inc. | $504.59 | 34 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,140 | 140 | PFIZER INC. ($421.83) |
| 2023 | $3,277 | 149 | Merck Sharp & Dohme LLC ($333.35) |
| 2022 | $2,509 | 123 | Novartis Pharmaceuticals Corporation ($330.39) |
| 2021 | $1,688 | 92 | Novartis Pharmaceuticals Corporation ($226.11) |
| 2020 | $1,613 | 84 | Merck Sharp & Dohme Corporation ($291.61) |
| 2019 | $1,539 | 92 | Novartis Pharmaceuticals Corporation ($328.89) |
| 2018 | $963.53 | 69 | E.R. Squibb & Sons, L.L.C. ($193.78) |
| 2017 | $1,353 | 89 | Novartis Pharmaceuticals Corporation ($204.05) |
All Payment Transactions
838 individual payment records from CMS Open Payments — Page 1 of 34
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/30/2024 | Celgene Corporation | REBLOZYL (Biological) | Food and Beverage | Cash or cash equivalent | $18.08 | General |
| Category: Hematology | ||||||
| 12/17/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $28.76 | General |
| Category: ONCOLOGY | ||||||
| 12/12/2024 | Celgene Corporation | REBLOZYL (Biological) | Food and Beverage | Cash or cash equivalent | $21.20 | General |
| Category: Hematology | ||||||
| 12/07/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $26.82 | General |
| 12/06/2024 | GlaxoSmithKline, LLC. | JEMPERLI (Biological), ZEJULA | Food and Beverage | In-kind items and services | $26.46 | General |
| Category: ONCOLOGY | ||||||
| 12/06/2024 | GlaxoSmithKline, LLC. | JEMPERLI (Biological), ZEJULA | Food and Beverage | In-kind items and services | $12.28 | General |
| Category: ONCOLOGY | ||||||
| 12/05/2024 | PFIZER INC. | BOSULIF (Drug), ELREXFIO, ADCETRIS | Food and Beverage | In-kind items and services | $19.95 | General |
| Category: METABOLIC DISEASE;ONCOLOGY | ||||||
| 12/03/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA | Food and Beverage | In-kind items and services | $14.50 | General |
| Category: Oncology | ||||||
| 11/26/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $12.36 | General |
| Category: ONCOLOGY | ||||||
| 11/25/2024 | GENZYME CORPORATION | SARCLISA (Biological) | Food and Beverage | In-kind items and services | $14.49 | General |
| Category: Oncology | ||||||
| 11/22/2024 | BeiGene USA, Inc. | TEVIMBRA (Drug) | Food and Beverage | In-kind items and services | $33.98 | General |
| Category: Oncology | ||||||
| 11/22/2024 | TerSera Therapeutics LLC | Zoladex (Drug) | Food and Beverage | In-kind items and services | $27.93 | General |
| Category: Oncology | ||||||
| 11/19/2024 | E.R. Squibb & Sons, L.L.C. | KRAZATI (Drug) | Food and Beverage | Cash or cash equivalent | $23.79 | General |
| Category: Oncology | ||||||
| 11/15/2024 | Fennec Pharmaceuticals, Inc. | Pedmark (Drug) | Food and Beverage | In-kind items and services | $25.44 | General |
| Category: Cisplatin-induced Ototoxicity | ||||||
| 11/13/2024 | Stemline Therapeutics Inc. | Orserdu (Drug) | Food and Beverage | In-kind items and services | $24.76 | General |
| Category: Oncology | ||||||
| 11/12/2024 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $16.29 | General |
| Category: Oncology | ||||||
| 11/08/2024 | Fresenius Kabi USA, LLC | Stimufend (Biological) | Food and Beverage | In-kind items and services | $18.91 | General |
| Category: Biosimilars | ||||||
| 11/06/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | GILOTRIF (Drug) | Food and Beverage | In-kind items and services | $13.98 | General |
| Category: ONCOLOGY | ||||||
| 11/05/2024 | Incyte Corporation | JAKAFI (Drug) | Food and Beverage | Cash or cash equivalent | $29.56 | General |
| Category: Hematology/Oncology | ||||||
| 11/04/2024 | Novartis Pharmaceuticals Corporation | PLUVICTO (Drug) | Food and Beverage | In-kind items and services | $12.65 | General |
| Category: Oncology | ||||||
| 11/01/2024 | PUMA BIOTECHNOLOGY, INC. | — | Food and Beverage | In-kind items and services | $22.34 | General |
| 11/01/2024 | Celgene Corporation | REBLOZYL (Biological) | Food and Beverage | Cash or cash equivalent | $15.36 | General |
| Category: Hematology | ||||||
| 10/30/2024 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $22.09 | General |
| Category: Oncology | ||||||
| 10/25/2024 | Lilly USA, LLC | VERZENIO (Drug), JAYPIRCA | Food and Beverage | In-kind items and services | $22.05 | General |
| Category: Oncology | ||||||
| 10/24/2024 | Novartis Pharmaceuticals Corporation | LUTATHERA (Drug) | Food and Beverage | In-kind items and services | $32.30 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 28 | 1,189 | 40,621 | $305,048 | $98,492 |
| 2022 | 27 | 1,117 | 22,464 | $311,032 | $93,010 |
| 2021 | 33 | 1,462 | 21,719 | $430,144 | $139,126 |
| 2020 | 30 | 1,207 | 48,368 | $572,760 | $174,042 |
Total Patients
4,975
Total Services
133,172
Medicare Billing
$504,670
Procedure Codes
118
All Medicare Procedures & Services
118 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| Q5106 | Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units | Office | 2023 | 17 | 3,283 | $57,322 | $17,816 | 31.1% |
| J1439 | Injection, ferric carboxymaltose, 1 mg | Office | 2023 | 11 | 14,250 | $42,750 | $12,559 | 29.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 72 | 124 | $38,440 | $11,500 | 29.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 52 | 52 | $27,924 | $8,739 | 31.3% |
| Q0138 | Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | Office | 2023 | 23 | 19,380 | $19,380 | $7,592 | 39.2% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 15 | 73 | $22,411 | $7,268 | 32.4% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 39 | 93 | $14,043 | $4,521 | 32.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 45 | 66 | $14,454 | $4,319 | 29.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 140 | 458 | $8,216 | $3,787 | 46.1% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 138 | 460 | $10,780 | $3,501 | 32.5% |
| 96367 | Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | Office | 2023 | 21 | 141 | $9,588 | $3,106 | 32.4% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 91 | 212 | $6,754 | $2,194 | 32.5% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 40 | 193 | $6,562 | $2,030 | 30.9% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 11 | 14 | $5,978 | $1,945 | 32.5% |
| 82728 | Ferritin (blood protein) level | Office | 2023 | 77 | 141 | $4,794 | $1,884 | 39.3% |
| 83735 | Magnesium level | Office | 2023 | 54 | 139 | $2,363 | $913.23 | 38.6% |
| 83615 | Lactate dehydrogenase (enzyme) level | Office | 2023 | 68 | 139 | $2,085 | $822.88 | 39.5% |
| 83540 | Iron level | Office | 2023 | 66 | 120 | $1,920 | $760.80 | 39.6% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2023 | 35 | 51 | $1,938 | $753.78 | 38.9% |
| 84100 | Phosphate level | Office | 2023 | 51 | 116 | $1,392 | $539.40 | 38.8% |
| 96375 | Injection of additional new drug or substance into vein | Office | 2023 | 13 | 39 | $1,443 | $458.59 | 31.8% |
| 82378 | Carcinoembryonic antigen (cea) protein level | Office | 2023 | 16 | 24 | $1,128 | $445.92 | 39.5% |
| 82746 | Folic acid level, serum | Office | 2023 | 24 | 25 | $925.00 | $360.25 | 38.9% |
| 82784 | Gammaglobulin (immune system protein) measurement | Office | 2023 | 13 | 36 | $828.00 | $328.06 | 39.6% |
| 84466 | Transferrin (iron binding protein) level | Office | 2023 | 13 | 13 | $416.00 | $162.50 | 39.1% |
About Dr. Syed Abid, MD
Dr. Syed Abid, MD is a Specialist healthcare provider based in St Petersburg, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/15/2005. The National Provider Identifier (NPI) number assigned to this provider is 1013902006.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Syed Abid, MD has received a total of $16,083 in payments from pharmaceutical and medical device companies, with $3,140 received in 2024. These payments were reported across 838 transactions from 79 companies. The most common payment nature is "Food and Beverage" ($14,942).
As a Medicare-enrolled provider, Abid has provided services to 4,975 Medicare beneficiaries, totaling 133,172 services with total Medicare billing of $504,670. Data is available for 4 years (2020–2023), covering 118 distinct procedure/service records.
Ad
Practice Information
- Specialty Specialist
- Other Specialties Hematology & Oncology
- Location St Petersburg, FL
- Active Since 09/15/2005
- Last Updated 08/31/2020
- Taxonomy Code 174400000X
- Entity Type Individual
- NPI Number 1013902006
Products in Payments
- OPDIVO (Biological) $1,108
- KEYTRUDA (Biological) $985.33
- IMBRUVICA (Drug) $454.17
- IBRANCE (Drug) $443.61
- KISQALI (Drug) $418.14
- LYNPARZA (Drug) $374.11
- Enhertu (Drug) $369.02
- XTANDI (Drug) $311.26
- PROMACTA (Drug) $296.98
- Cabometyx (Drug) $291.02
- MEKINIST (Drug) $250.99
- JAKAFI (Drug) $249.95
- INLYTA (Drug) $226.74
- KRAZATI (Drug) $187.11
- REBLOZYL (Biological) $184.49
- ADCETRIS (Biological) $182.93
- Nplate (Biological) $182.28
- GILOTRIF (Drug) $176.77
- INJECTAFER (Drug) $166.07
- LIBTAYO (Biological) $160.64
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in St Petersburg
Dr. Margarita Nunez, M.d, M.D
Specialist — Payments: $121,572
Specialist $121,572
Dr. Robert Sanchez, M.d, M.D
Specialist — Payments: $17,649
Specialist $17,649
Dr. Donna Stephens, M.d, M.D
Specialist — Payments: $8,938
Specialist $8,938
Dr. William Bria, M.d, M.D
Specialist — Payments: $6,494
Specialist $6,494
Dr. Ramona Arias, M.d, M.D
Specialist — Payments: $5,397
Specialist $5,397
Dr. Brien Pierpont, M.d, M.D
Specialist — Payments: $3,018
Specialist $3,018